Staying current with emerging research is essential for delivering evidence-based allergy and rhinology care. The latest AAOA Journal Club session provides a valuable review of recent literature impacting the diagnosis and management of allergic and inflammatory conditions encountered in otolaryngology…
Targeted Molecular Therapies in Allergy and Rhinology
AAOA’s “Targeted Molecular Therapies in Allergy and Rhinology” (Damask C. et al) was published in the Bulletin.
The past decade has seen a rapid expansion in the use of biologic drugs for the treatment of numerous chronic inflammatory diseases.
Biologic drugs are monoclonal antibodies targeting specific Type ll inflammation molecular pathways for a variety of disease entities in the head and neck.
Read the article here:




